Literature DB >> 20802247

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

A John Camm, Paulus Kirchhof, Gregory Y H Lip, Ulrich Schotten, Irene Savelieva, Sabine Ernst, Isabelle C Van Gelder, Nawwar Al-Attar, Gerhard Hindricks, Bernard Prendergast, Hein Heidbuchel, Ottavio Alfieri, Annalisa Angelini, Dan Atar, Paolo Colonna, Raffaele De Caterina, Johan De Sutter, Andreas Goette, Bulent Gorenek, Magnus Heldal, Stefan H Hohloser, Philippe Kolh, Jean-Yves Le Heuzey, Piotr Ponikowski, Frans H Rutten.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20802247     DOI： 10.1093/eurheartj/ehq278

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  1131 in total

Review 1.  Chemical transmitter systems in the brain.

Authors:  C C Shute
Journal:  Mod Trends Neurol       Date:  1975

2.  MEDEX South Carolina: a progress report.

Authors:  K J Buhmeyer; A R Hutson
Journal:  J S C Med Assoc       Date:  1975-11

3.  Fast atrial fibrillation and caecal volvulus--a case report and evidence based management.

Authors:  Alexander Liu; Edward Nicol
Journal:  BMJ Case Rep       Date:  2011-12-20

Review 4.  Balancing ischaemia and bleeding risks with novel oral anticoagulants.

Authors:  Usman Baber; Ioannis Mastoris; Roxana Mehran
Journal:  Nat Rev Cardiol       Date:  2014-11-04       Impact factor: 32.419

5.  Continuation of vitamin K antagonists as acceptable anticoagulation regimen in patients undergoing pulmonary vein isolation.

Authors:  B Oude Velthuis; J Stevenhagen; J M van Opstal; M F Scholten
Journal:  Neth Heart J       Date:  2012-01       Impact factor: 2.380

6.  Appropriateness of antiplatelet therapy for primary and secondary cardio- and cerebrovascular prevention in acutely hospitalized older people.

Authors:  Ilaria Ardoino; Raffaella Rossio; Donnatella Di Blanca; Alessandro Nobili; Luca Pasina; Pier Mannuccio Mannucci; Flora Peyvandi; Carlotta Franchi
Journal:  Br J Clin Pharmacol       Date:  2017-08-01       Impact factor: 4.335

7.  Dabigatran and vitamin K antagonists' use in naïve patients with non-valvular atrial fibrillation: a cross-sectional study of primary care-based electronic health records.

Authors:  Bogdan Vlacho; Maria Giner-Soriano; Edurne Zabaleta-Del-Olmo; Albert Roso-Llorach; Ana García-Sangenís; Rosa Morros-Pedrós
Journal:  Eur J Clin Pharmacol       Date:  2017-07-19       Impact factor: 2.953

Review 8.  Oral Anticoagulation.

Authors:  Ertunc Altiok; Nikolaus Marx
Journal:  Dtsch Arztebl Int       Date:  2018-11-16       Impact factor: 5.594

9.  Impact of epicardial ablation of concomitant atrial fibrillation on atrial natriuretic peptide levels and atrial function in 6 months follow-up: does preoperative ANP level predict outcome of ablation?

Authors:  Marek Pizon; Norbert Friedel; Monika Pizon; Miriam Freundt; Michael Weyand; Richard Feyrer
Journal:  J Cardiothorac Surg       Date:  2013-11-28       Impact factor: 1.637

10.  Cost-effectiveness of apixaban vs. other new oral anticoagulants for the prevention of stroke: an analysis on patients with non-valvular atrial fibrillation in the Greek healthcare setting.

Authors:  Kostas Athanasakis; Eleftheria Karampli; Dimitrios Tsounis; Aikaterini Bilitou; John Kyriopoulos
Journal:  Clin Drug Investig       Date:  2015-11       Impact factor: 2.859
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.